E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 0.76 (1.08%)
Intraday High$71.42
Intraday Low$70.28
Data as of 03/02/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
Quest Diagnostics Earns Fortune Magazine 2015 "World's Most Admired Companies" Designation
MADISON, N.J., Feb. 20, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named a "Most Admired Company" by Fortune Magazine in the "Health Care: Pharmacy and Other Services" category. "We are proud that Quest Diagnostics is included on FORTUNE's 2015 World's Most Admired Companies list in our category," said Steve Rusckowski, President and CEO. "The honor is a true team accomplishment, and ... 
Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation
Agreement ensures continuing broad patient access to Quest's BRCAvantage™ services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb. 9, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.  Under the agreement, Quest Diagnostics and Myriad Genetics and its co-... 
Quest Diagnostics Reports Fourth Quarter and Full Year 2014 Financial Results; Provides Guidance For Full Year 2015; Increases Dividend 15%
MADISON, N.J., Jan. 29, 2015 /PRNewswire/ -- Fourth quarter revenues from continuing operations of $1.9 billion, up 7.2% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 4.9% versus prior year Reported diluted EPS from continuing operations of $1.26, up 30% versus prior year Dividend increased 15% to $0.38 per quarter Full year 2015 revenues to grow 2% to 3% Full year 2015 adjusted diluted EPS excluding amortization expense expected to be between $4.... 
Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and Treatment
Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitis MADISON, N.J. and ATLANTA, Jan. 28, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention (CDC) to identify tre... 
Upcoming EventsMore >
There are currently no events scheduled.
Contact Us:
Dan Haemmerle
Executive Director Investor Relations

Company Calendar
March 2015?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.